Effect of Madhumehadaman choorna and phaltrikadi kwath in management of Type 2 Diabetes Mellitus.

Phase 2

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2023/04/052065
• Lead Sponsor: Ayurvedic and Unani Tibbia College Hospital.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1-Patients of either sex aged between 20-65 years

2-If yes in any two of four :

Blood sugar fasting- 125 - 150 mg/dl.

PP- 199-250 mg/dl.

Glycosylated Haemoglobin (HbA1c) 6.4% - 7.5%

Subjects having classical symptoms of diabetes with random glucose levels

>=200mg/dl (<=250mg/dl)

3-Subjects who are able to come for follow up on fixed visits and are well aware about

the treatment plan.(only type 2 DM patients)

4-Subjects willing to participate and able to provide written informed consent.

Exclusion Criteria

1-Subject on any other AYUSH medication for glucose control.

2- Patients with type 1 Diabetes Mellitus.

3-Subjects suffering from the complications of Diabetes mellitus viz., diabetic

neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent

treatment.

4-Uncontrolled Hypertensive subjects (BP with or without medication >140/90 mmHg

after 5 mins of rest).

5-Subjects with any unstable Heart disease or known cases of MI, unstable angina or

CHF.

6-Subjects with current or past diagnosis of malignancy (any malignancy diagnosis in

last five years).

7-Subjects who have a recent history or who are currently known to abuse of alcohol

or drugs.

8-Subjects suffering from major systemic illness necessitating long term drug

treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, TB, AIDS etc).

9-Subjects having hypersensitivity to any of the trial drug.

10- Subjects who have completed participation in any other clinical trial during the past

six (06) months.

11- Pregnancy and lactating mothers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified